支气管哮喘是一种慢性气道炎症性疾病。
Allergic bronchial asthma is characterized by chronic airway inflammation.
支气管哮喘是一种慢性气道炎症性疾病。
Bronchial asthma is a chronicity airway inflammation disease.
COPD与哮喘均属于慢性气道炎症性疾病。
COPD and asthma are chronic inflammatory diseases of the airways.
因此，深入研究核受体及其配体的作用将为慢性气道炎症性疾病展现广阔的治疗前景。
Therefore, further investigation of nuclear receptors and their ligands may reveal a novel potential therapeutic prospect for chronic airway inflammation.
结论哮喘病是一种慢性气道炎症性疾病，在不同发病时期气道内的炎性细胞变化不同。
ConclusionAsthma is a kind of diseases characterized by chronic inflammation of airway. The composition of inflammatory cells in the airway was different during the diversity phase of the asthma.
目的：观察合成药qty 06对大鼠气管滴入脂多糖诱发的慢性气道炎症及黏蛋白表达的影响。
Objective: To investigate the effect of synthetic drug QTY06 on chronic airway inflammation and mucoprotein expression induced by intratracheal instillation of lipopolysaccharide.
故在本研究中，我们建立了SD大鼠慢性气道炎症模型，并观察了蓝按油在气道炎症和粘蛋白高分泌中的作用。
In our research, we set up the models of SD rats chronic airway inflammation, and observe the effect of eucalyptus globulus oil on chronic airway inflammation and mucin hypersecretion.
背景与目的哮喘是慢性气道免疫性炎症，以气道淋巴细胞、嗜酸性粒细胞浸润、气道高反应性、粘液产生增加为特征。
Background and Objective Asthma is chronic airway immune inflammation characterized by airway lymphocyte infiltration and eosinophilia, airway hyperresponsiveness (AHR) and mucus hypersecretion.
背景与目的哮喘是慢性气道免疫性炎症，以气道淋巴细胞、嗜酸性粒细胞浸润、气道高反应性、粘液产生增加为特征。
Background and Objective Asthma is chronic airway immune inflammation characterized by airway lymphocyte infiltration and eosinophilia, airway hyperresponsiveness (AHR) and mucus hypersecretion.
应用推荐